Donald B. Rice
Director/Board Member at Nammi Therapeutics, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert Bradway | M | 61 | 18 years | |
Jerry Perkins | M | 54 | 22 years | |
Thompson Baker | M | 66 | 17 years | |
David Stover | M | - |
Nammi Therapeutics, Inc.
Nammi Therapeutics, Inc. BiotechnologyHealth Technology Nammi Therapeutics, Inc. specializes in prodrug design that allows for efficient and stable incorporation into nammisomes. The American company's technology maintains immune modulating agents in an inactive state until released by intracellular esterases, and provides IP and FTO. The private company was founded by David Stover. David Stover has been the CEO since incorporation. | - |
Lee Styslinger | M | 63 | 11 years | |
Mary Carlisle | F | 43 | 18 years | |
Esteban Santos | M | 56 | 17 years | |
David Reese | M | 61 | 19 years | |
Cynthia Hostetler | F | 60 | 10 years | |
Joseph Rice | M | 59 |
Nammi Therapeutics, Inc.
Nammi Therapeutics, Inc. BiotechnologyHealth Technology Nammi Therapeutics, Inc. specializes in prodrug design that allows for efficient and stable incorporation into nammisomes. The American company's technology maintains immune modulating agents in an inactive state until released by intracellular esterases, and provides IP and FTO. The private company was founded by David Stover. David Stover has been the CEO since incorporation. | 9 years |
O. Hall | M | 66 | 10 years | |
Matthew Busch | M | 50 | 20 years | |
Martha E. Vincent | M | - |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | 29 years |
Richard O'Brien | M | 70 | 16 years | |
Robert Eckert | M | 69 | 21 years | |
James Prokopanko | M | 70 | 15 years | |
Thomas Fanning | M | 66 | 9 years | |
Lindsay T. Lewellen | M | - | 23 years | |
Derek Miller | M | - | 21 years | |
Mark D. Warren | M | - | 24 years | |
John Campbell | M | - | 29 years | |
Mike Zahigian | M | - | 23 years | |
Janet F. Kavinoky | F | - | 9 years | |
Scott Primeau | M | - | 16 years | |
Kyle Hranicky | M | - | 29 years | |
Frank Van Buren | M | - | 26 years | |
George M. Ayoub | M | - |
Nammi Therapeutics, Inc.
Nammi Therapeutics, Inc. BiotechnologyHealth Technology Nammi Therapeutics, Inc. specializes in prodrug design that allows for efficient and stable incorporation into nammisomes. The American company's technology maintains immune modulating agents in an inactive state until released by intracellular esterases, and provides IP and FTO. The private company was founded by David Stover. David Stover has been the CEO since incorporation. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Timothy Sloan | M | 63 | 32 years | |
Donald James | M | 75 | 23 years | |
Paul M. Hazen | M | 82 | 14 years | |
David W. Beier | M | 75 | 10 years | |
Avid Modjtabai | F | 62 | 27 years | |
John Stumpf | M | 69 | 14 years | |
Michael Kelly | M | 67 | 14 years | |
Danny Shepherd | M | 73 | 14 years | |
Kathryn Falberg | F | 63 | 6 years | |
John Baker | M | 74 | 13 years | |
William P. Rutledge | M | 82 |
Teledyne, Inc.
Teledyne, Inc. Other Metals/MineralsNon-Energy Minerals Teledyne, Inc. is a technology-based manufacturing businesses. It is engaged in serving customers with specialty metals for consumer, industrial and aerospace applications; commercial and government-related aviation and electronics products and consumer and industrial products. The company was founded by Henry Singleton and George Kozmetsky in 1960 and is headquartered in Akron, OH. | 3 years |
Stephen W. Sanger | M | 78 | 14 years | |
Dick M. Kovacevich | M | 80 | 11 years | |
Kevin A. Rhein | M | 70 | 7 years | |
Paul Eisenberg | M | - | 14 years | |
Patricia R. Callahan | F | 70 | 22 years | |
Michael Severino | M | 58 | 10 years | |
James Daly | M | 62 | 9 years | |
David Quint | M | 74 |
University of Notre Dame
| 7 years |
David Berman | M | - | 27 years | |
John Smither | M | 71 | 6 years | |
Orin Port | M | - | 2 years | |
Jin Long Chen | M | 61 | 4 years | |
Jacob Susman | M | - | 2 years | |
Cynthia Flowers | F | 64 | 5 years | |
Erin Lavelle | F | 46 | 15 years | |
Jean-Pierre Murray | M | 56 |
Pepperdine University
| 4 years |
William Ashton | M | 73 | 16 years | |
Willard Dere | M | 70 | 11 years | |
Gregory L. Tewalt | M | - | - | |
Preston Klassen | M | 55 | 7 years | |
Jenny Tanujaya | F | 59 |
Pepperdine University
| 6 years |
Thomas Zindrick | M | 65 | 8 years | |
David Kreuter | M | - |
University of Notre Dame
| 7 years |
Cynthia Patton | F | 62 | 15 years | |
Charles J. Dougherty | M | 75 |
University of Notre Dame
| 2 years |
Diana McKenzie | F | 59 | 12 years | |
Craig Shepherd | M | - | 7 years | |
Vasant Prakash Gandhi | M | - | 5 years | |
Tom C. Gores | M | - |
University of Notre Dame
| 7 years |
Sean E. Harper | M | 61 | 16 years | |
John Moriarty | M | 56 | 6 years | |
Leonard Schaeffer | M | 78 | 9 years | |
Christopher D. Davies | M | 58 | 18 years | |
Richard D. McCormick | M | 83 | 28 years | |
George Morrow | M | 72 | 10 years | |
Brian M. McNamee | M | 67 | - | |
Vincent J. Trosino | M | 82 | 14 years | |
Arie Belldegrun | M | 74 |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | 11 years |
Kathleen Wilson-Thompson | F | 66 | 9 years | |
William J. Schmuhl | M | 80 |
University of Notre Dame
| 6 years |
Dominique Monnet | M | 65 | 11 years | |
Carl E. Reichardt | M | 93 | 11 years | |
H. Allen Franklin | M | 79 | 13 years | |
Judith M. Runstad | F | 79 | 18 years | |
William F. Zuendt | M | 77 | 24 years | |
Frank Herringer | M | 81 | 15 years | |
Susan Swenson | F | 75 | 23 years | |
Paul E. Knauss | M | - |
University of Notre Dame
| 6 years |
Philip J. Quigley | M | 81 | 19 years | |
Anna Richo | F | 63 | 9 years | |
Roberto Pedro Rosenkranz | M | 74 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 1 years |
John Lewicki | M | 72 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 17 years |
J. Reason | M | 83 | 12 years | |
Sean C. O'Keefe | M | 68 |
US Department of Defense (District of Columbia)
| - |
Nicholas G. Moore | M | 82 | 7 years | |
Tom McIntyre | M | - |
University of Notre Dame
| 6 years |
Mark Tomkins | M | 68 | 4 years | |
Barry X. Lynn | M | - | 16 years | |
Frank J. Biondi | M | 79 | 15 years | |
Dan Sansone | M | 71 | 26 years | |
Kevin M. Butler | M | 68 |
University of Notre Dame
| 6 years |
Crystal Voss | F | - | 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Donald B. Rice
- Personal Network